BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/31/2024 7:40:52 AM | Browse: 311 | Download: 883
Publication Name World Journal of Experimental Medicine
Manuscript ID 98543
Country United States
ISSN 2220-315x (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Meta-Analysis
Article Title Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis
Manuscript Source Invited Manuscript
All Author List Zahid Ijaz Tarar, Umer Farooq, Faisal Inayat, Sanket D Basida, Faisal Ibrahim, Mustafa Gandhi, Gul Nawaz, Arslan Afzal, Ammad J Chaudhary, Faisal Kamal, Ahmad H Ali and Yezaz A Ghouri
ORCID
Author(s) ORCID Number
Zahid Ijaz Tarar http://orcid.org/0000-0001-7562-7420
Faisal Inayat http://orcid.org/0000-0001-7576-7319
Sanket D Basida http://orcid.org/0000-0002-1029-6453
Yezaz A Ghouri http://orcid.org/0000-0002-8677-1871
Funding Agency and Grant Number
Corresponding Author Faisal Inayat, Department of Internal Medicine, Allama Iqbal Medical College, Allama Shabbir Ahmad Usmani Road, Faisal Town, Punjab 54550, Pakistan. faisalinayat@hotmail.com
Key Words Metabolic dysfunction-associated steatotic liver disease; Hepatocellular carcinoma; Statins; Lipophilic statin; Hydrophilic statin; Meta-analysis
Core Tip Current clinical evidence regarding the effect of statins on lowering the risk of hepatocellular carcinoma (HCC) among patients with metabolic dysfunction-associated steatotic liver disease (MASLD) is inconclusive. We performed a systematic review and meta-analysis of all the studies that evaluated the impact of statins on HCC occurrence in MASLD patients. The pooled data from four studies involving 291684 patients was included in the final analysis. Our findings show that statin use reduces the risk of HCC among patients with MASLD. The use of higher cumulative defined daily doses and lipophilic statins results in a significant reduction in HCC risk.
Publish Date 2024-10-31 07:40
Citation

Tarar ZI, Farooq U, Inayat F, Basida SD, Ibrahim F, Gandhi M, Nawaz G, Afzal A, Chaudhary AJ, Kamal F, Ali AH, Ghouri YA. Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis. World J Exp Med 2024; 14(4): 98543

URL https://www.wjgnet.com/2220-315x/full/v14/i4/98543.htm
DOI https://dx.doi.org/10.5493/wjem.v14.i4.98543
Full Article (PDF) WJEM-14-98543-with-cover.pdf